Mastodawn

"PEGyAMPH: A Novel Anti-Obesity Agent"
- 🧠 Brain-sparing treatment alters sympathetic activity
- 🧊 Increases NE, lipolysis, and thermogenesis
- 🩺 No cardiovascular side effects observed
- 🐁 Maintains normothermia through tail vasodilation

#ObesityResearch #DrugDevelopment https://tnyp.me/kzRoO838/m

Genelife Clinical Research Jun 3

Reposting:
In our latest article, we examine why recruitment failures are almost always predictable — built into protocol design, site selection, and planning decisions made months before the first patient is screened.
We also share how our Disease Surveillance Research (DSR) methodology — built on data from 800+ investigators across India.
www.genelifecr.com
#ClinicalTrials #PatientRecruitment #ClinicalResearch #CRO #India #DrugDevelopment #ClinicalOperations
https://genelifecr.blogspot.com/2026/04/patient-recruitment-challenges-in.html

Patient Recruitment Challenges in Clinical Trials and How to Overcome Them

learn about Genelife Clinical Research Smarter Patient Recruitment Through Disease Surveillance

Show thread

LED3hub May 21

#Science #Entrepeneurship #Company #StartUp #Founding #DrugDiscovery #DrugDevelopment #Chemistry #ChemBio
(7/7)

Genelife Clinical Research May 15

Reposting this article as the topic continues to remain highly relevant for sponsors planning clinical trials in India.

Selecting the right CRO can significantly influence study execution, compliance, patient recruitment, and overall development timelines.

In this article, we share practical considerations for choosing a CRO partner aligned with both scientific and operational goals.

#ClinicalResearch #CROIndia #ClinicalTrials #DrugDevelopment

https://genelifecr.blogspot.com/2026/04/how-to-choose-cro-in-india-key-factors.html

How to Choose a CRO in India: Key Factors to Consider

Learn the key factors for selecting a CRO in India for your clinical trials.

Genelife Clinical Research May 13

We published an article on Monday about India's biosimilar regulatory framework.

We are reposting the article again, in case you missed that:

https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html

Biosimilar Regulation in India: Evolving Landscape and Current Perspectives

Explore India’s evolving biosimilar regulatory framework, including CDSCO guidelines, analytical comparability, PK/PD studies, and pharmacovigilance

Genelife Clinical Research May 11

Our latest article explores the changing regulatory framework for biosimilars in India.

As the industry moves toward a more science-driven and risk-based approach, understanding the evolving biosimilar ecosystem becomes increasingly important for sponsors, researchers, and healthcare stakeholders.

https://genelifecr.blogspot.com/2026/05/biosimilar-regulation-in-india-evolving.html

Biosimilar Regulation in India: Evolving Landscape and Current Perspectives

Explore India’s evolving biosimilar regulatory framework, including CDSCO guidelines, analytical comparability, PK/PD studies, and pharmacovigilance

Show thread

Stephan Hacker May 9

Congratulations to @[email protected] and all others involved at @[email protected], Arvinas and Pfizer. #InducedProximity should be at the top of many The Nobel Prize lists now. #TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success #ChemSky #ChemBio

Show thread

Stephan Hacker May 9

Congratulations to Craig @crews and all others involved at Yale University, Arvinas and Pfizer. #InducedProximity should be at the top of many Nobel Prize lists now. (2/2)

#TPD #TargetedProteinDegradation #NewModalities #Clinics #DrugDiscovery #DrugDevelopment #Success

Genelife Clinical Research May 8

Genelife Clinical Research offers end-to-end clinical research solutions, including clinical operations, data management, regulatory affairs, and pharmacovigilance services.

Contact us today to discuss your clinical research requirements.
Visit us: https://www.genelifecr.com
#genelife #ClinicalResearch #ClinicalTrials #IndianCRO #ClinicalResearch #CRO #Pharma #DrugDevelopment

https://www.linkedin.com/pulse/clinical-trial-process-india-complete-step-by-step-guide-sponsors-ji5tf

Genelife® Clinical Research Pvt. Ltd. | CRO India

Genelife® Clinical Research is a global CRO in India offering clinical trial services for pharmaceutical, biotechnology and medical device companies.

Genelife® Clinical Research Pvt. Ltd.

Genelife Clinical Research May 7

Genelife Clinical Research offers end-to-end clinical research solutions, including clinical operations, data management, regulatory affairs, and pharmacovigilance services.

#genelife #ClinicalResearch #ClinicalTrials #IndianCRO #ClinicalResearch #CRO #Pharma #DrugDevelopment

https://www.linkedin.com/pulse/what-cro-role-clinical-research-organizations-india-genelifecr-2rhtf

What is a CRO? Role of Clinical Research Organizations in India

Introduction The journey from a promising molecule to an approved medicine can take over a decade and cost upwards of $2.6 billion.